Showing results (41-50 of 109) with videos related to
Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2014
Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B poreZhifen Zhang, Minyoung Park, John Tam, et al.Journal of Bacteriology|September 28, 2010
Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacAKelly A Gangwer, Carrie L Shaffer, Sebastian Suerbaum, et al.The Journal of Biological Chemistry|March 27, 2004
Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigenDarran J Wigelsworth, Bryan A Krantz, Kenneth A Christensen, et al.Infection and Immunity|November 30, 2022
Redistribution of the Novel Clostridioides difficile Spore Adherence Receptor E-Cadherin by TcdA and TcdB Increases Spore Binding to Adherens JunctionsPablo Castro-Córdova, Macarena Otto-Medina, Nicolás Montes-Bravo, et al.Microbial Genomics|October 8, 2020
Comparative genomics of Clostridioides difficile toxinotypes identifies module-based toxin gene evolutionSandra Janezic, Kate Dingle, Joseph Alvin, et al.The Journal of Biological Chemistry|June 10, 2011
Studies of the mechanistic details of the pH-dependent association of botulinum neurotoxin with membranesDarren J Mushrush, Hanane A Koteiche, Morgan A Sammons, et al.Biochimica Et Biophysica Acta|November 8, 1979
The isolation of bovine-heart cytochrome c oxidase subunits. Dependence on phospholipid and cholate-contentF E Verheul, J C Boonman, J W Draijer, et al.Plos One|March 29, 2007
Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formationHeather M Scobie, John M Marlett, G Jonah A Rainey, et al.The Journal of Biological Chemistry|January 24, 2012
Structural determinants of Clostridium difficile toxin A glucosyltransferase activityRory N Pruitt, Nicole M Chumbler, Stacey A Rutherford, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 29, 2001
Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release systemM A Attawia, M D Borden, K M Herbert, et al.Pageof 11